Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1384 of 6351
-
New hope for rare lung disease: JAK inhibitors vs standard care
Disease control Recruiting nowThis study is a prospective investigation comparing the efficacy and safety of Janus kinase inhibitors versus calcineurin inhibitors as initial therapy for interstitial lung disease associated with antisynthetase syndrome. The goal is to determine which treatment is more effectiv…
Sponsor: China-Japan Friendship Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
Hearing loss shield: new drug may protect ears during chemo
Symptom relief Recruiting nowThe purpose of this study is to assess the safety and effectiveness of a drug called Pedmark® sodium thiosulfate (STS) in reducing hearing impairment with standard of care cisplatin therapy. The safety and effectiveness of STS in reducing hearing loss has been well established in…
Phase 1/2 • Sponsor: University of Arizona • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
New drug DA-3501 takes on tough cancers in first human trial
Disease control Recruiting nowThe goal of this clinical trial is to determine the MTD or OBED of DA-3501 given in Q3W to determine a wRP2D in patients with advanced CLDN18.2 expressing (CLDN18.2+) GC/GEJ and advanced CLDN18.2+ PDAC. Participants will receive the assigned dose once every three weeks and, acco…
Phase 1 • Sponsor: Dong-A ST Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Could a simple talk therapy help struggling mothers in peru? new trial aims to find out
Disease control Recruiting nowRecent advances in intervention research have revealed the promise of transdiagnostic, modular approaches implemented by lay paraprofessionals for the treatment of the most prevalent mental health concerns in settings affected by adversity (e.g., anxiety, depression, posttraumati…
Phase 2 • Sponsor: University of Notre Dame • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New drug combo targets tough breast cancer in Real-World study
Disease control Not yet recruitingA Multicenter, Observational Study on the Real-World Effectiveness and Safety of inavolisib Combined with Endocrine Therapy With or Without a CDK4/6 Inhibitor in Patients with HR-Positive/HER2-Negative, PIK3CA-Mutated Advanced Breast Cancer.
Sponsor: xuliang • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Neck injection offers new hope for Tough-to-Treat PTSD
Symptom relief Recruiting nowPTSD is a chronic mental health condition that drastically reduces an individual's quality of life Dextrose injection with a small needle has been used for chronic pain patients and observational results have shown it to be effective in reducing anxiety, brain fog, and depression…
Phase 4 • Sponsor: Dr. Dean Reeves Clinic • Aim: Symptom relief
Last updated Jun 27, 2026 12:35 UTC
-
New drug combo aims to tackle obesity in major trial
Disease control Recruiting nowThe main purpose of this study, performed under the master protocol W8M-MC-CWMM (NCT06143956), is to examine the body weight-lowering efficacy and safety of macupatide plus eloralintide compared with placebo in participants with obesity or overweight and without type 2 diabetes. …
Phase 2 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
New pill targets Hard-to-Treat cancers in early human trial
Disease control Not yet recruitingThis is a Phase Ia/Ib clinical study of FS-207, an investigational oral tablet, in patients with advanced solid tumors that are microsatellite instability-high, also called MSI-H. MSI-H tumors have specific changes in DNA repair pathways and may depend on the WRN protein to survi…
Phase 1 • Sponsor: Foresight Therapeutics (Hefei) Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New Alzheimer's drug ABBV-1758 enters early human trials
Disease control Recruiting nowAlzheimer's disease (AD) is a progressive, irreversible neurological disorder and is the most common cause of dementia in the elderly population. Clinical symptoms of the disease may begin with occasional forgetfulness such as misplacement of items, forgetting important dates or …
Phase 1/2 • Sponsor: AbbVie • Aim: Disease control
Last updated Aug 27, 2026 00:00 UTC
-
New combo drug trial hopes to shrink Hard-to-Treat cancers
Disease control Not yet recruitingThis study is a multi-center, open-label, dose-escalation and dose-optimized phase I/II clinical trial. Objective: To determine the safety, tolerability, PK characteristics and preliminary efficacy data of CVL006 combined with 9MW821 patients with advanced solid tumors.
Phase 1/2 • Sponsor: Convalife (Shanghai) Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Magnetic pulses aim to restore speech after stroke
Symptom relief Recruiting nowThis project aims to tailor repetitive Transcranial Magnetic Stimulation (rTMS) target to the clinical profile of post-stroke aphasia, specifically focusing on lexicosemantic impairments, to enhance recovery. Functional Magnetic Resonance Imaging (fMRI) will provide critical insi…
Sponsor: University of South Carolina • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC
-
New drug cocktail aims to boost lung cancer treatment before radiation
Disease control Not yet recruitingThe goal of this clinical trial is to compare the efficacy and safety of induction Benmelstobart plus Anlotinib and chemotherapy followed by concurrent chemoradiotherapy (CCRT) and subsequent Benmelstobart maintenance versus CCRT followed by Benmelstobart maintenance in patients …
Phase 2 • Sponsor: The Third Xiangya Hospital of Central South University • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Can a care checklist speed up recovery from lung cancer surgery?
Knowledge-focused Recruiting nowThis prospective observational study will evaluate the association between ERAS protocol compliance and postoperative nutritional outcomes in 120 patients undergoing lung cancer surgery. ERAS compliance will be recorded, and patients will be classified as having high, moderate, o…
Sponsor: Bursa City Hospital • Aim: Knowledge-focused
Last updated Aug 27, 2026 00:00 UTC
-
New cream aims to tame burn scars – trial underway
Symptom relief Recruiting nowThe goal of this study is to see how an ingredient called kynurenic acid (which we named "FS2") affects scar formation in people with burn injuries that need skin graft surgery. A cream with FS2 will be used on both the area where the skin graft was placed and the area where the …
Phase 2/3 • Sponsor: Birch BioMed Inc • Aim: Symptom relief
Last updated Jun 27, 2026 12:29 UTC
-
Can 3D-printed guides tame the toughest spine screws?
Knowledge-focused OngoingThis retrospective, single-center observational study evaluates the clinical safety and neurophysiological performance of patient-specific MySpine guides (Medacta International) for pedicle screw placement in patients undergoing instrumented spinal surgery. Particular attention i…
Sponsor: I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio • Aim: Knowledge-focused
Last updated Aug 29, 2026 00:00 UTC
-
One pill to prevent HIV and pregnancy? new study tests simpler option for women
Prevention Not yet recruitingTo evaluate adherence to a single dual-prevention pill (DPP) compared with a two-pill regimen (2PR) for pre-exposure prophylaxis (PrEP) and pregnancy prevention in women without HIV.
Phase 2 • Sponsor: HIV Prevention Trials Network • Aim: Prevention
Last updated Jun 27, 2026 09:06 UTC
-
New drug cocktail targets Hard-to-Treat lung cancer
Disease control Recruiting nowThis research is being done to test a combination of two drugs, Izalontamab Brengitecan (iza-bren) and Adagrasib, in patients with advanced KRAS G12C-mutant NSCLC that hasn't responded to other treatments. The purpose is to see if this combination works better than existing treat…
Phase 1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
MRNA injection aims to turn back the clock on aging
Disease control Not yet recruitingThis is a Phase 1b randomized, double-blind, placebo-controlled study to assess the safety and tolerability of a proprietary aKLmRNA formulated in lipid nanoparticles. Approximately 21 subjects will be enrolled. Each subject will receive a total of two injections during the stud…
Phase 1 • Sponsor: Klothea Bio Inc • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Can VR games restore lost vision in young brain tumor survivors?
Symptom relief Not yet recruitingEvaluate the efficiency of audiovisual stimulation in virtual reality for improving the visual perception of children, adolescents, and young adults with hemianopia resulting from pediatric brain tumors. These individuals can lose up to 50% of their visual field, significantly im…
Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: Symptom relief
Last updated Jun 27, 2026 12:25 UTC
-
Could Low-Dose radiation slow Alzheimer's? new trial aims to find out
Disease control Not yet recruitingThe goal of this randomized clinical trial is to investigate whether low-dose whole-brain radiotherapy has a potential immunomodulatory effect that may influence disease progression in patients with early-stage Alzheimer's disease (ICD-10 diagnosed). The main question(s) it aims…
Sponsor: Heinrich-Heine University, Duesseldorf • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC